By
Stop TB Partnership
Published: Oct. 4, 2022, 10:53 p.m.·
Tags:
Global TB response,
Advocacy
TB community-led monitoring: Leaving no one behind
Read More →
By
World Health Organization
Published: Sept. 30, 2022, 2:35 p.m.·
Tags:
Diagnostics,
Guidelines
The World Health Organization releases updated guidelines and a new operational handbook on tests for the diagnosis of TB infection.
Read More →
By
Stop TB Partnership
Published: Sept. 27, 2022, 3:19 p.m.·
Tags:
Global TB response,
Advocacy
Statement by Dr. Lucica Ditiu, Executive Director of the Stop TB Partnership
Read More →
By
Sentinel Project on Pediatric Drug-Resistant Tuberculosis
Published: Sept. 19, 2022, 3:26 p.m.·
Tags:
Drug-resistant TB,
TB care,
Pediatrics
The Sentinel Project on Pediatric Drug-Resistant Tuberculosis releases a guide meant to support the care of pregnant and peripartum people with drug-resistant TB and the neonates born to them.
Read More →
By
ARK Foundation
Published: Sept. 14, 2022, 6:50 p.m.·
Tags:
TB programs,
Prevention,
Access,
Advocacy
Community monitoring mechanism highlights the gaps in the existing isoniazid preventive therapy program in the country and clearly indicates the high demand for 3HP.
Read More →
By
Médecins Sans Frontières
Published: Sept. 14, 2022, 4 p.m.·
Tags:
Diagnostics,
Access,
Advocacy
A shortage of TB tests at this critical juncture will be disastrous.
Read More →
By
World Health Organization
Published: Aug. 17, 2022, 9:41 p.m.·
Tags:
Global TB response,
Advocacy
WHO Director-General and WHO Civil Society Task Force on TB release a joint statement setting collective priorities in preparation for the 2023 UN High-Level Meeting on TB.
Read More →
By
Treatment Action Group
Published: Aug. 1, 2022, 4 p.m.·
Tags:
Global TB response,
Advocacy
At the International AIDS Conference in Montreal, civil society and activist organizations launched a new campaign inspired by the legacy of the late Dr. Paul Farmer calling for the “staff, stuff, space, systems, and support” necessary for shorter, effective TB treatment regimens to reach all who need them as a human right by the end of 2024.
Read More →
By
Unitaid
Published: Aug. 1, 2022, noon·
Tags:
Prevention,
Access
Partners announce two new agreements to lower the price of rifapentine-based treatments to prevent TB in low- and middle-income countries.
Read More →
By
Treatment Action Group
Published: July 21, 2022, 3:37 p.m.·
Tags:
Advocacy,
Access,
Research and development,
Global TB response,
TB CAB
In 2021, TB CAB celebrated its tenth anniversary of advocating for community engagement in research and improved access to TB prevention, treatment, and diagnostic technologies.
Read More →
Page 17 of 133 · Total posts: 10
←First
16
17
18
Last→